Pharma firms ‘need to do more’ to counter superbugs

SANDALS Resorts (728 x 90)

Drugmakers’ response to the threat posed by “superbugs” remains patchy even after years of warnings, according to the first analysis of individual companies’ efforts to tackle the antibiotic resistance crisis.

Wal-Mart.com USA, LLC